Merrimack Pharmaceuticals Stock Price and Value Analysis

Should you buy Merrimack Pharmaceuticals stock? (NasdaqGM:MACK). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the MACK Numbers

MACK Price
(Merrimack Pharmaceuticals stock price per share)
$9.15
[?] PE Ratio versus Sector 98% lower than other Healthcare stocks
[?] PE Ratio versus Industry 99% lower than other Biotechnology stocks
[?] Cash Yield -4.32%
[?] Free Cash Flow Jitter 37%

Is Merrimack Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Merrimack Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy MACK Stock?

Does Merrimack Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.